Please use this identifier to cite or link to this item:
Title: Positron emission tomography/computerised tomography imaging in detecting and managing recurrent cervical cancer: systematic review of evidence, elicitation of subjective probabilities and economic modelling.
Authors: Meads, C
Auguste, P
Davenport, C
Małysiak, S
Sundar, S
Kowalska, M
Zapalska, A
Guest, P
Thangaratinam, S
Martin-Hirsch, P
Borowiack, E
Barton, P
Roberts, T
Khan, K
Keywords: Asymptomatic diseases;Chemoradiotherapy;Cost-benefit analysis;Female;Great Britain;Humans;Hysterectomy;Magnetic resonance imaging;Economic models;Pelvic exenteration;Positron-emission tomography and computed tomography;Quality-adjusted life years;Recurrence;Sensitivity and specificity;State medicine;Survival analysis;X-ray computed tomography;Uterine cervical neoplasms
Issue Date: 2013
Publisher: BioMed Central
Citation: Health Technology Assessment, 17(12), 1 - 323, 2013
Abstract: Cancer of the uterine cervix is a common cause of mortality in women. After initial treatment women may be symptom free, but the cancer may recur within a few years. It is uncertain whether it is more clinically effective to survey asymptomatic women for signs of recurrence or to await symptoms or signs before using imaging.
Description: © Queen’s Printer and Controller of HMSO 2013. This work was produced by Meads et al. under the terms of a commissioning contract issued by the Secretary of State for Health. This issue may be freely reproduced for the purposes of private research and study and extracts (or indeed, the full report) may be included in professional journals provided that suitable acknowledgement is made and the reproduction is not associated with any form of advertising.
Appears in Collections:Publications
Community Health and Public Health
Health Economics Research Group (HERG)

Files in This Item:
File Description SizeFormat 
Fulltext.pdf2.48 MBAdobe PDFView/Open

Items in BURA are protected by copyright, with all rights reserved, unless otherwise indicated.